Showing results (11-20 of 1,656) with videos related to
Sort By:
Pageof 166
Atherosclerosis. Supplements|November 4, 2017
Lipoprotein apheresis influences monocyte subpopulationsS Jellinghaus, C Reich, U Schatz, et al.Atherosclerosis. Supplements|January 30, 2013
Current situation of lipoprotein apheresis in SaxonyU Julius, K Taseva, S Fischer, et al.Atherosclerosis. Supplements|January 30, 2013
Factors inducing cardiovascular events in patients treated by lipoprotein apheresisK Taseva, S Fischer, J Passauer, et al.Atherosclerosis. Supplements|January 30, 2013
Differences in the atherogenic risk of patients treated by lipoprotein apheresis according to their lipid patternM von Dryander, S Fischer, J Passauer, et al.Atherosclerosis. Supplements|January 30, 2013
Regular lipoprotein apheresis maintains residual cardiovascular and microvascular function in patients with advanced atherosclerotic diseaseM Reimann, U Julius, S R Bornstein, et al.Atherosclerosis. Supplements|January 30, 2013
Lipoprotein apheresis reduces adipocyte fatty acid-binding protein serum levelsV Lamounier-Zepter, C Look, M Ehrhart-Bornstein, et al.Atherosclerosis. Supplements|January 30, 2013
Homocysteine in lipoprotein apheresis patients--retrospective data analysis in apheresis center of a university hospitalS Tselmin, R N Rodionov, G Müller, et al.Atherosclerosis. Supplements|May 5, 2015
Adverse events of lipoprotein apheresis and immunoadsorption at the Apheresis Center at the University Hospital DresdenJ Dittrich-Riediger, U Schatz, B Hohenstein, et al.Atherosclerosis. Supplements|January 30, 2013
Nicotinic acid as a lipid-modifying drug--a reviewU Julius, S FischerDer Internist|March 12, 2008
[New oral antidiabetic agents--clinical perspectives]S Fischer, S R BornsteinPageof 166